Literature DB >> 16609746

Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics.

Nickie D Greer1.   

Abstract

Entities:  

Year:  2006        PMID： 16609746      PMCID： PMC1426172          DOI： 10.1080/08998280.2006.11928154

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  17 in total

1.  Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

Authors:  Joseph S Solomkin; John E Mazuski; Ellen J Baron; Robert G Sawyer; Avery B Nathens; Joseph T DiPiro; Timothy Buchman; E Patchen Dellinger; John Jernigan; Sherwood Gorbach; Anthony W Chow; John Bartlett
Journal:  Clin Infect Dis       Date:  2003-09-25       Impact factor: 9.079

2.  Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Diagn Microbiol Infect Dis       Date:  2004-10       Impact factor: 2.803

3.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Dale Everett; Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Edward L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2005-10-14       Impact factor: 9.079

4.  Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.

Authors:  Gopal Muralidharan; Marlynne Micalizzi; John Speth; Donald Raible; Steven Troy
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Tigecycline: clinical evidence and formulary positioning.

Authors:  Dilip Nathwani
Journal:  Int J Antimicrob Agents       Date:  2005-03       Impact factor: 5.283

6.  Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.

Authors:  María Eugenia Pachón-Ibáñez; Manuel Enrique Jiménez-Mejías; Cristina Pichardo; Ana Cristina Llanos; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii.

Authors:  Alexey Ruzin; David Keeney; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections.

Authors:  Thomas R Fritsche; Ronald N Jones
Journal:  Int J Antimicrob Agents       Date:  2004-12       Impact factor: 5.283

9.  Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients.

Authors:  Russell G Postier; Stephen L Green; Stanley R Klein; E J Ellis-Grosse; Evan Loh
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393

10.  Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA.

Authors:  Gesine Bauer; Christian Berens; Steven J Projan; Wolfgang Hillen
Journal:  J Antimicrob Chemother       Date:  2004-02-25       Impact factor: 5.790
View more
  26 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statistics.

Authors:  Paul G Ambrose; Jeffrey P Hammel; Sujata M Bhavnani; Christopher M Rubino; Evelyn J Ellis-Grosse; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

3.  Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study.

Authors:  Muammer Ozcimen; Yasar Sakarya; Serap Ozcimen; Sertan Goktas; Rabia Sakarya; Ismail Alpfidan; Erkan Erdogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-23       Impact factor: 3.117

4.  Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Authors:  Stephen W Barthold; Emir Hodzic; Denise M Imai; Sunlian Feng; Xiaohua Yang; Benjamin J Luft
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 6.  Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.

Authors:  Ayman M Noreddin; Virginia Haynes
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay.

Authors:  Dina Elgazzar; Mohamed Aboubakr; Heba Bayoumi; Amany N Ibrahim; Safwa M Sorour; Mohamed El-Hewaity; Abulmaaty M Elsayed; Shaimaa A Shehata; Khaled A Bayoumi; Mohammed Alsieni; Maged Behery; Doaa Abdelrahaman; Samah F Ibrahim; Ahmed Abdeen
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-10

8.  In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.

Authors:  David W Hecht; Minerva A Galang; Susan P Sambol; James R Osmolski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens.

Authors:  Michelle C Maciag; Stephanie L Ward; Amy E O'Connell; Ana D Broyles
Journal:  Ann Allergy Asthma Immunol       Date:  2020-02-20       Impact factor: 6.347

10.  WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective.

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  BMC Microbiol       Date:  2021-07-10       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.